caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1558348433

Patrick StiffMD

Hematology-OncologyMaywood, ILI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Patrick Stiff's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 13 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
LOYOLA UNIVERSITY MEDICAL CENTER2062,357
NPI 105348053323114
Aileen Go
Hematology-Oncology · Maywood, IL
19128
SMITH, SCOTT19215
Davide Bova
Diagnostic Radiology · Maywood, IL
1636
Aruna Vade
Diagnostic Radiology · Maywood, IL
1559
Joseph Yacoub
Diagnostic Radiology · Maywood, IL
1558
Jennifer Lim-Dunham
Diagnostic Radiology · Maywood, IL
1348
Yi Lin
Diagnostic Radiology · Maywood, IL
1231
Nancy Porter
Nurse Practitioner · Maywood, IL
1239
Robert Wagner
Diagnostic Radiology · Maywood, IL
1138
DUDIAK, CHRISTINE1133
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
75
Unique beneficiaries
—
Total services
238
Distinct HCPCS
3
Medicare payment
$24K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 444 Hematology-Oncology providers in IL — bottom quintile (cohort median 1,266).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$3K
Payment records
1
By payment type
Consulting Fee$3K
PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
—
Total drug cost
$167K
Distinct drugs
1
Brand share
100.0%
Top prescribed drugs
Acalabrutinib Maleate11 claims